About the ICA Foundation                     About the product                     About the projects

The product

How does the product work?

How effective is the product?

Patient Information



The Levonorgestrel Intrauterine System (LNG-IUS) is a T-shaped plastic device placed in the uterus that steadily releases small amounts of levonorgestrel each day. The T-body adjusts the system to the shape of the uterus and the vertical arm of the T-body carries the drug reservoir containing the hormone. Two threads are tied to the system which exit from the cervix to assist in its removal and to allow the user to ensure its presence. Levonorgestrel is the progestin hormone released from the IUS, provided locally in the uterus, at a steady dose for up to five years.

LNG-IUS functions by:
  • Thickening the mucus in the cervix so that sperm cannot get through to fertilize the egg.
  • Keeping the lining of the uterus (endometrium) thin.
  • Reducing the mobility of sperm so that they are less likely to reach or fertilize the egg.
  • Preventing ovulation in some women during some cycles.
Additional to the protection against pregnancy, there are additional health benefits associated with use of LNG-IUS. These benefits may include the reduction of iron-deficiency anemia, reduction of menorrhagia (excessive menstrual bleeding) and the lessening of menstrual cramps and symptoms of endometriosis.


         Board of Trustees         Contact         Partners         Disclaimer